about
Evaluation of the Architect Epstein-Barr Virus (EBV) viral capsid antigen (VCA) IgG, VCA IgM, and EBV nuclear antigen 1 IgG chemiluminescent immunoassays for detection of EBV antibodies and categorization of EBV infection status using immunofluorescNeed to evaluate the performance of real-time PCR assays for the quantitation of cytomegalovirus DNA load in lower respiratory tract specimens.Monitoring of trough plasma ganciclovir levels and peripheral blood cytomegalovirus (CMV)-specific CD8+ T cells to predict CMV DNAemia clearance in preemptively treated allogeneic stem cell transplant recipients.Cytomegalovirus Infection Management in Allogeneic Stem Cell Transplant Recipients: a National Survey in Spain.Efficacy and Safety of a Preemptive Antiviral Therapy Strategy Based on Combined Virological and Immunological Monitoring for Active Cytomegalovirus Infection in Allogeneic Stem Cell Transplant RecipientsEarly kinetics of plasma cytomegalovirus DNA load in allogeneic stem cell transplant recipients in the era of highly sensitive real-time PCR assays: does it have any clinical value?Impact of cytomegalovirus DNAemia on overall and non-relapse mortality in allogeneic stem cell transplant recipients.Cytomegalovirus infection management in solid organ transplant recipients across European centers in the time of molecular diagnostics: An ESGICH survey.IL28B genetic variation and cytomegalovirus-specific T-cell immunity in allogeneic stem cell transplant recipients.Lack of evidence for a reciprocal interaction between bacterial and cytomegalovirus infection in the allogeneic stem cell transplantation setting.The impact of virus population diversity on the dynamics of cytomegalovirus DNAemia in allogeneic stem cell transplant recipients.Reproducible measurement of vancomycin MICs within the susceptible range in Staphylococcus aureus by a broth microdilution method with a "quasi-continuum" gradient of antibiotic concentrations.Dynamics of Torque Teno virus plasma DNAemia in allogeneic stem cell transplant recipients.Assessing the risk of cytomegalovirus DNAaemia in allogeneic stem cell transplant recipients by monitoring oxidative-stress markers in plasma.When should preemptive antiviral therapy for active CMV infection be withdrawn from allogeneic stem cell transplant recipients?Comparison of the artus Epstein-Barr virus (EBV) PCR kit and the Abbott RealTime EBV assay for measuring plasma EBV DNA loads in allogeneic stem cell transplant recipients.Plasma metabolomics profiling for the prediction of cytomegalovirus DNAemia and analysis of virus–host interaction in allogeneic stem cell transplant recipients.High vancomycin MICs within the susceptible range in Staphylococcus aureus bacteraemia isolates are associated with increased cell wall thickness and reduced intracellular killing by human phagocytes.Preemptive antiviral therapy for CMV infection in allogeneic stem cell transplant recipients guided by the viral doubling time in the blood.Functional patterns of cytomegalovirus (CMV) pp65 and immediate early-1-specific CD8(+) T cells that are associated with protection from and control of CMV DNAemia after allogeneic stem cell transplantation.Effect of delaying prophylaxis against CMV in D+/R- solid organ transplant recipients in the development of CMV-specific cellular immunity and occurrence of late CMV disease.Effect of long-term prophylaxis in the development of cytomegalovirus-specific T-cell immunity in D+/R- solid organ transplant recipients.Enumeration of NKG2C+ natural killer cells early following allogeneic stem cell transplant recipients does not allow prediction of the occurrence of cytomegalovirus DNAemia.Role of cytomegalovirus (CMV)-specific polyfunctional CD8+ T-cells and antibodies neutralizing virus epithelial infection in the control of CMV infection in an allogeneic stem-cell transplantation setting.Association between individual and combined SNPs in genes related to innate immunity and incidence of CMV infection in seropositive kidney transplant recipients.Comparison of the performance of 2 commercial multiplex PCR platforms for detection of respiratory viruses in upper and lower tract respiratory specimens.Detection of fungal DNA in peritoneal fluids by a PCR DNA low-density microarray system and quantitation of serum (1-3)-β-D-glucan in the diagnosis of peritoneal candidiasis.Incidence and dynamics of active cytomegalovirus infection in allogeneic stem cell transplant patients according to single nucleotide polymorphisms in donor and recipient CCR5, MCP-1, IL-10, and TLR9 genes.Looking for biological factors to predict the risk of active cytomegalovirus infection in non-immunosuppressed critically ill patients.Effect of the IL28B Rs12979860 C/T polymorphism on the incidence and features of active cytomegalovirus infection in allogeneic stem cell transplant patients.An evaluation of the role of NKG2C+ natural killer cells in protection from cytomegalovirus DNAemia early following allogeneic stem cell transplantation.An investigation on the relationship between the occurrence of CMV DNAemia and the development of invasive aspergillosis in the allogeneic stem cell transplantation setting.Evaluation of cytomegalovirus (CMV)-specific T-cell immunity for the assessment of the risk of active CMV infection in non-immunosuppressed surgical and trauma intensive care unit patients.Epstein-Barr virus DNA load kinetics analysis in allogeneic hematopoietic stem cell transplant recipients: Is it of any clinical usefulness?The kinetics of torque teno virus plasma DNA load shortly after engraftment predicts the risk of high-level CMV DNAemia in allogeneic hematopoietic stem cell transplant recipients.Active cytomegalovirus infection is not a risk factor for Epstein-Barr virus DNAemia in the allogeneic stem cell transplantation setting.Pre-emptive antiviral therapy for active CMV infection in adult allo-SCT patients guided by plasma CMV DNAemia quantitation using a real-time PCR assay: clinical experience at a single center.Short-term incubation of positive blood cultures in brain-heart infusion broth accelerates identification of bacteria by matrix-assisted laser desorption/ionization time-of-flight mass-spectrometry.Epidemiologic and Clinical Characteristics of Coronavirus and Bocavirus Respiratory Infections after Allogeneic Stem Cell Transplantation: A Prospective Single-Center Study.Re-examining the relationship between active cytomegalovirus (CMV) infection and acute graft-versus-host disease in allogeneic stem cell transplant recipients in the era of real-time PCR CMV assays.
P50
Q33601876-A00A4424-3F38-45C9-A8C7-29C73149021FQ33762239-675B3F1C-2FCA-4426-8BBC-EE390F1305C7Q34057379-0A5F40DD-C383-472C-9ABD-FB4B03BB162CQ35868731-DB6BE632-BDF5-4F8B-9271-63C897308AFDQ37091612-11ADFCA2-11AC-4712-B935-989CA760D908Q37546310-495F18FF-0B18-4D47-A3DD-983F864EC9D4Q38805253-8D1A9EE7-B03F-4AD1-995D-CEC09142DB3EQ39296120-3D3E76BB-CF7B-4985-B826-475571B9F75EQ39425526-0F777D92-98C3-45D3-BFB2-83AF72BBEB14Q39486182-9EACA6C4-60FA-4519-AD3F-309D1AEC48E5Q40057047-EF55E3B6-AA12-4F0C-99EC-111DEAC4615BQ40121177-D5C8D3F6-3A18-422A-A0B6-6010AA449984Q40121730-2EF3CB1E-CE12-461A-8103-CAD7C40DD56AQ40129654-2F9B7A26-C301-48BA-92EF-A86E9A80F826Q40185135-7976BCFF-7659-499D-BFB7-E3C800AE70DEQ40301686-C5BDDAB9-6577-494F-A09E-DCEDFD987F0EQ40572348-F481A87B-2744-4D69-8D97-60827875D9CCQ40723943-84272A7A-0CC8-4B91-9A53-4125C804AD01Q40880905-4B63E073-27DA-499B-A4A7-277179B92AC8Q41104283-0895C67C-41A8-44E5-92D8-628A739C774EQ41104403-6BCE91EC-2702-4331-A21C-ED096F05C48FQ41128262-75C16BD8-1417-4EE9-BCF2-112CFEC928CFQ41172989-3DB5890E-3196-4481-ADCE-9A9062314168Q41195272-46F06A1B-3F7B-432D-8F87-6833BE63F658Q41427501-15FF9F7E-560F-441A-87C3-FEBB975EE993Q41459364-F40EEDEF-F6D3-4CCF-842A-87E5AB8671A8Q41581019-05A81527-8649-4A46-8B4C-BE2F3FBD2D47Q42199375-9C12CF8B-7854-410C-B9BD-24A5D513F574Q42242953-EC16010C-224C-4411-A559-0323556A6F13Q42246332-D8618AA8-EEF0-4A5B-A83C-5BC1F3B601A0Q42263994-64739DA9-E455-44EC-98CE-115809B1C281Q42269481-FC8F22B9-1CE9-4900-9904-CAB524EB13D2Q42282848-7FC6B495-439D-46DE-8554-E15023DDE561Q45325374-1196DAC1-4B4E-41D2-BB25-81E75A9FA2EFQ45325509-4AD9DA8A-8E11-4F4B-8A90-661D16C637DAQ45347053-FB3F95AF-C373-4158-BD15-05918A5D08F3Q45398742-804B9BF7-52C5-409A-B818-54B83924623BQ46261852-ED5F3DB2-B4BF-4E3E-BCD9-BA01602E7A24Q47444851-795C801B-CAA2-438F-8E14-E284ED8A9AE3Q50963422-A55388D9-4220-4D94-895E-712DBF8F5A54
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0003-1774-9790
@en
name
Estela Giménez
@ast
Estela Giménez
@en
Estela Giménez
@es
Estela Giménez
@nl
type
label
Estela Giménez
@ast
Estela Giménez
@en
Estela Giménez
@es
Estela Giménez
@nl
prefLabel
Estela Giménez
@ast
Estela Giménez
@en
Estela Giménez
@es
Estela Giménez
@nl
P106
P1153
55485325600
P31
P496
0000-0003-1774-9790